Account Details

First Name *
Surname *
Employer Code *
Email *
Password *
Confirm Password *
Gender *
Date of Birth *
Work Post code *
(use home if not applicable)
Phone Number


Terms & Conditions


You may use this web site providing you agree to these terms of use.

you do not agree to these terms of use, please refrain from using the service. If you use our service, you will be deemed to have accepted the terms. Health Assured reserves the right to change the terms of use by posting any changes on the site. The new terms will be effective immediately upon posting.

Our terms explain the use for our website and online consulting services, twitter feeds, RSS feeds and other services available through the website(the “Site”). The terms apply to you as a registered user.

Who we are

This content of the website is owned and controlled by Health Assured Limited. Registered in England and Wales No. 06314620. Registered Address: The Peninsula, Victoria Place, Manchester, M4 4FB, UK (Peninsula Business Services)

To Our Site & Services

to the Site is permitted to our registered members, and we reserve the right to amend the service we provide on the Site without notice. We will not be liable if for any reason if the Site is unavailable at any time or for any period. From time to time, we may restrict access to some parts of the Site and / or to users who have registered with us.

You are responsible for making all arrangements necessary for you to have access to the Site. You are also responsible for ensuring that all persons who access the Site through your internet connection are aware of our terms of use.

Registration on the Site

Access and registration to the Site is restricted to individuals who are 16 years of age or older. Registration is available to you if you hold a current valid membership to an organisation for which we are providing the Site to or to our retail members. To register with the Site you will be asked to provide certain personal information about yourself that is accurate and complete.

Please inform us of any changes to the information provided when registering. Once we have accepted your registration you will have access to the Site and services for up to twelve months. We reserve the right at any time to decline or terminate your registration for any reason.

Importantly, your registration is for you only. We don’t permit shared usernames or passwords with any other person.

Membership Fees

We operate 2 fee structures within our business. If there is a sponsoring party (e.g. corporate) there are no fees payable by an individual user associated with the use of any part of our services. We also accept retail members who pay the subscription fee upon registration to the Site. Health Assured provides links to other sites on the Web and some of these sites may assess separate charges for their content, goods or services. Costs, taxes or other charges you incur when visiting these websites are your responsibility.

Personal Details

On registering with our services you will select your own username and password. Please treat your password confidentially, and you must not disclose it to any third party. We have the right to disable any user password, whether chosen by you, at any time, if in our opinion you have failed to comply with any of the provisions of these terms of use.

Intellectual Property Rights

The Site and all of the related pages, including but not limited to content, permitted modifications to the software, graphics or other material contained either in advertisements or electronically distributed on the Site is owned by Health Assured and hosted and maintained by Expert 24 who own the underlying software and source code. The Site is protected by copyrights, trademarks, service marks, patents or other proprietary rights and laws.

Unauthorised use of any copyrighted materials, trademarks or any other intellectual property without the expressed written consent of the owner is strictly prohibited.

Our works are protected by copyright laws and treaties around the world. All such rights are reserved.

and Service changes

The Site is upgraded regularly and we will continually upgrade our content and interactive services available to our members on the Site. We may need to suspend access to the Site to permit these upgrades going live on the site. We will endeavour to minimise any disruptions to the Site while performing these service upgrades.

Should any of the material on the Site be out of date we will aim to update it, however, we are under no obligation to do so.

Content Standards

Our content standards apply to all of the material published on the Site and to any of the services associated with it.

Contributions aim to: 1. Be accurate and genuinely held (where they state facts);
2. Comply with applicable law in the UK and in any country from which they are posted.

Contributions must not: 1. Contain any material which is defamatory of any person;
2. Contain any material which is obscene, offensive, hateful or inflammatory;
3. Promote sexually explicit material;
4. Promote violence;
5. Promote discrimination based on race, sex, religion, nationality, disability, sexual orientation or age;
6. Infringe any copyright, database right or trademark of any other person; 7. Be likely to deceive any person;
8. Be made in breach of any legal duty owed to a third party, such as a contractual duty or a duty of confidence;
9. Promote illegal activity;
10. Be threatening, abusive or invade another’s privacy, or cause annoyance, inconvenience or needless anxiety;
11. Be likely to harass, upset, embarrass, alarm or annoy any other person;
12. Be used to impersonate any person, or to misrepresent your identity or affiliation with any person.
13. Give the impression that they emanate from us, if this is not the case; and 14. Advocate, promote or assist any unlawful act such as (by way of an example) copyright infringement or computer misuse.

Visitor and Member Conduct

Should you make use of any feature that allows you to upload material to the Site, you must comply with the content standards set out in these terms. You warrant that any such contribution does comply with those standards, and you indemnify us for any breach of that warranty. Other personally identifiable information which is covered under our Privacy Policy, any material you upload or transmit to the Site will be considered non-confidential and non-proprietary, and we have the right to use, copy, distribute and disclose to third parties any such material for any purpose. We also have the right to disclose your identity to any third party who is claiming that any material posted or uploaded by you to the Site constitutes a violation of their intellectual property rights, or of their right to privacy. We will not be responsible, or liable to any third party, for the content or accuracy of any materials posted by you or any other user of the Site. We have the right to remove any material or posting you make on the Site if, in our opinion, such material does not comply with the content standards set out in these terms.

Privacy and Cookie Policy

When you supply any personal information to the Site we have legal obligations towards you in the way we deal with that data.

We will hold your personal information on our systems for as long as needed to meet the service you have requested, and remove it in the event that the purpose has been met. We will ensure that all personal information supplied is held securely, in accordance with the Data Protection Act 1998.

The information which we collect and store during normal use of the Site is used to monitor and analyse how parts of the Site are used. Such use does not result in any personally identifiable data being collected or stored.

Our online service is committed to protecting the privacy of our users. We aim to provide a safe and secure experience for users of this site. We will use our best efforts to ensure that the information you submit to us remains private, and is only used for the purposes set out in this policy.

Cookie Policy

cookie is a small amount of data sent to your computer or mobile phone from a website. This means the website can recognise your device (your computer or mobile phone) if you return to the same site.

cookie often includes a unique identifier, which is a randomly generated number. This is stored on your device's hard drive. Many cookies are automatically deleted after you finish using a website.

Cookies are not programs and do not collect information from your device.

Cookies make your experience of using websites faster and easier. They allow websites to create a customised view of pages to which you navigate. For example, they are commonly used to authenticate or identify registered users of a website without requiring them to sign in each time they access it, and tracking the pages a user has visited on a site for analysis purposes.

How to control and delete cookies

Health Assured will not use cookies to collect personally identifiable information about you. However, if you wish to restrict or block the cookies which are set by this website, or indeed any other website, you can do this through your browser settings.

How to manage your cookies

Cookies are sent to your browser (whether you use Internet Explorer, Google Chrome, Safari or any other browser) by a website and then stored in the cookies directory of your device.

To check and update your cookies settings, you will need to know what browser you are using and what version of it you have. You can usually find this out by opening the browser (just as though you were going to use the internet) and then clicking on 'Help' and then 'About'. This will give you information about the browser version you are using.

To find out how to allow, block, delete and manage the cookies on all standard web browsers, go to and select the browser and version you are using. You'll also find information about how to delete cookies from your computer.

you use a mobile phone to browse this site or other sites that use cookies, please refer to your handset manual for guidance.

Service Use:

Our members are responsible for their own communications on the Site or related sites (twitter, facebook, other).

The following actions are prohibited and will constitute a material breach of our terms: 1. Posting advertisements or solicitations of business;
2. Posting chain letters of pyramid schemes;
3. Collecting information about other users, including email addresses without their consent;
4. Posting the same comments more than once or "spamming"; and
5. Engaging in any conduct that restricts or inhibits any other person from using or enjoying The Site or which in our judgment exposes us or any of our users or contributors to any liability or detriment of any type.

Offensive Material

The Site may contain or direct you to health related material which is sexually explicit or which you may find offensive. If you do not want to view or may be offended by such material do not use the Site.

Posted Information

Commentary and other materials posted on the Site are not intended to amount to advice on which reliance should be placed. We therefore disclaim all liability and responsibility arising from any reliance placed on such materials by any visitor to the Site, or by anyone who may be informed of any of its contents. The material provided on the Site is not intended to be a substitute for professional medical advice, diagnosis or treatment. You should always seek the advice of a suitably qualified medical practitioner with any questions or concerns you have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on the Site.


We will endeavour to ensure that the information on the Site is correct; we do not warrant the accuracy and completeness of the material on the Site. The material on the Site is provided "as is", without any conditions, warranties or other terms of any kind. We provide you with the Site on the basis that we exclude all representations, warranties, conditions and other terms (including, without limitation, the conditions implied by law of use of reasonable care and skill) which, but for these terms of service, might have effect in relation to the Site.

Viruses, Hacking etc

Please do not misuse the Site by knowingly introducing viruses, trojans, worms, logic bombs or other material which is malicious or technologically harmful. You must not attempt to gain unauthorised access to the Site, the server on which the Site is stored or any server, computer or database connected to the Site. Do not attack the Site via a denial-of-service attack or a distributed denial-of service attack. By breaching this provision, you would commit a criminal offence under the Computer Misuse Act 1990. In the event of such a breach, your right to use the Site will cease immediately. We will not be liable for any loss or damage caused by a distributed denial-of-service attack, viruses or other technologically harmful material that may infect your computer equipment, computer programs, data or other proprietary material due to your use of the Site or to your downloading of any material posted on it, or on any website linked to it.

Site Links

Links to our home page are permitted so long as you have our written (email) consent to do so. If we provider our consent you must do so in a way that is fair and legal and does not damage our reputation. You must not establish a link in such a way as to suggest any form of association, approval or endorsement on our part where none exists. The Site must not be framed on any other site, nor may you create a link to any part of the Site other than the home page. We reserve the right to withdraw linking permission without notice. The website from which you are linking must comply in all respects with the content standards set out in our terms. If you wish to make any use of material on the Site other than that set out above, please address your request to


The material displayed on the Site is provided without any guarantees, conditions or warranties as to its accuracy. To the extent permitted by law, we and third parties connected to us hereby expressly exclude: 1. All conditions, warranties and other terms which might otherwise be implied by statute, common law or the law of equity.
2. Any liability for any direct, indirect or consequential loss or damage incurred by any user in connection with the Site or in connection with the use, inability to use, or results of the use of the Site, any websites linked to it and any materials posted on it, including, without limitation any liability for:
a. loss of income or revenue;
b. loss of business;
c. loss of profits or contracts;
d. loss of anticipated savings;
e. loss of data;
f. loss of goodwill;
g. wasted management or office time; and
h. for any other loss or damage of any kind, however arising and whether caused by tort (including negligence), breach of contract or otherwise, even if foreseeable.

This does not affect our liability for death or personal injury arising from our negligence, or our liability for fraudulent misrepresentation or misrepresentation as to a fundamental matter, or any other liability which cannot be excluded or limited under applicable law. Indemnity & Warranties You agree to indemnify us, our offices, directors, employees and agents and keep us indemnified from and against all claims, liabilities, expenses and costs (including legal costs) relating to or arising directly or indirectly from any breaches by you of these terms. Health Assured does not give any warranty, condition, guarantee or representation, express or implied, relating to information contained on the Site or to any web site to which it is linked.

Term & Termination

Your registration will be renewed annually, subject to these terms. We may terminate your registration by giving notice by email of termination not less than 30 days and not more than 60 days prior to the expiry of any given 12 month registration period. We may terminate your registration as a user immediately by notice by email if you: 1. Breach these terms;
2. Commit any dishonest or fraudulent at; or
3. Behave in a manner which in our reasonable opinion might tend to adversely affect our reputation or public image.

Upon termination of your registration: 1. Your user name and password will be cancelled and you will no longer be able or entitled to access the Site or the services;
2. The perpetual license you have granted us to use your material shall continue;
3. Your license to use the material on the Site automatically terminates and you must immediately destroy any copies you have made of any portion of the material on the Site; and
4. Any provision of these terms which by their nature would be expected to survive termination, shall survive and remain in full force in accordance with their terms.

Assignment & Waiver

Your rights and obligations under these terms may not be transferred or assigned directly or indirectly without our prior written consent. A waiver by Health Assured of any breach or a failure to enforce or to insist on the observance of a condition of these terms will not be a waiver of any other or of any subsequent breach.


at any time any provision in these terms is or becomes invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions of the terms shall not be impaired.

Force Majeure

We will not be responsible or liable for failure to perform any obligation under these terms if such failure is caused by the occurrence of any matter beyond its reasonable control including, without limitation, internet and communications outages, fire, flood, war, or act of God.


Except as explicitly stated otherwise, all notices permitted or required under these terms shall be by email, to us at and to you at the email address you provide us during the registration process, or to such other address as either of us shall notify to the other in writing.

Applicable Law

These terms of use shall be governed and construed in accordance with English law and be subject to the exclusive jurisdiction of the English courts. If any term is held to be invalid, unlawful or unenforceable, it shall not affect the enforceability of any of the remaining terms.


We may revise these terms of use at any time by amending this page... Some of the provisions contained in these terms of use may also be superseded by provisions or notices published elsewhere on the Site.

Questions & feedback

you have any queries, feedback or comments about any of the material that appears on the Site, please contact us by email at

I have read and accept the Terms & Conditions

Password Policy

Passwords must have a minimum password length of 8 case-sensitive alphanumeric characters.
Passwords must not be the same as or derivation of (e.g. Password123):

• Username
• First name
• Last name
• Password
•Health assured

Expert Review Panel – Expert-24 Ltd

Terms of reference

The aim of the Expert Review Panel is to ensure that all Expert-24 clinical and epidemiological content is robust, independent and up to date.


· Reviewers are chosen for their expertise in fields such as medicine, public health, epidemiology and statistics.
· All practicing doctors are members of the appropriate Royal College.
· All practicing doctors participate in the appraisal process for their particular specialty, as applicable.

Medical Director and Editor

Dr. Timothy Dudley

Year of graduation: - 1980
Qualifications: -B.S., M.D.
Current Post: - Family Physician, Denver, Colorado, USA
Special Interests: - Health Information Technology
License last verified: - April 2011

Chairman of the Expert Review Panel

Dr. Robin Christie

Year of qualification: - 1977
Qualifications: - B.Sc,MB.ChB,MRCGP,DRCOG
Current Post: - GP,Hitchin, LMC member
Special Interests: - GP Tutor and GP Trainer
GMC registration last verified: - April 2011

Current authors and reviewers for the Health Risk Assessment

Dr. Martin Dawes

Year of qualification: - 1978
Qualifications: - MB.BS DRCOG MRCGP MD
Current Post: - Royal Canadian Legion Professor and Head
UBC Department of Family Practice
Special Interests: - Evidence Based Health Care, Ambulatory blood pressure monitoring, knowledge management.
GMC registration last verified: - April 2011

Dr. Jonathan Mant

Year of qualification: - 1985
Qualifications: - MA MSc MBBS MFPHM
Current Post: - Professor of Primary Care Research, University of Cambridge. Associate Director, Stroke Research Network.
Special Interests: - Stroke & cardiovascular disease
GMC registration last verified: - April 2011

Emeritus authors and reviewers for the Health Risk Assessment

The following individuals were deeply involved in the creation of the health risk assessment at its inception, but are no longer active reviewers on the panel:

Dr. John Fletcher

Year of qualification: - 1985
Qualifications: - MA Cambridge, MPH Harvard, MB BChir Cambridge, MRCGP (Membership of the Royal College of General Practitioners), MFPHM (Membership of the Faculty of Public Health Medicine of the Royal College of Physicians).
Current Post: - Deputy Editor, Canadian Medical Association Journal, Company Director, Oxford Health Consulting.
Special Interests: - Applied Epidemiology, uResearch Methods
GMC registration last verified: - April 2011

Dr. Emma Boulton

Year of qualification: - 1989
Qualifications: - MB BS DRACOG MPH
Current Post: - Director, Oxford Health Consulting. Senior Lecturer, University of Sydney
Special Interests: - Public Health medicine in industry, the private sector and Government health sector. International Public Health. Primary Care Development.
GMC registration last verified: - April 2011. Australian HPRA last verified April 2011

Professor Larry Ramsay

Year of qualification: -1966
Qualifications: - MB,ChB [Glasgow, 1966], FRCP
Current Post: - Retired, (until recently Professor of Clinical Pharmacology & Therapeutics, University of Sheffield, and Consultant Physician, Royal Hallamshire Hospital, Sheffield.)
Special Interests: - General and cardiovascular medicine; treatment of hypertension and lipid disorders; cardiovascular risk estimation
Additional information: - Author of over 300 articles, chapters, etc on above topics; previously President of British Hypertension Society and Editor of British Journal of Clinical Pharmacology

Professor Klim McPherson

Year of qualification: -1966
Qualifications: - PhD FFPHM, FMedSci
Current Post: - Retired, (until recently Visiting Professor of Public Health Epidemiology Nuffield Dept of Obstetrics and Gynaecology, Churchill Hospital, Oxford)
Special Interests: - Medical statistics, particularly regarding coronary heart disease and cancer prevention and the health of women.

References for the Health Risk Assessment

Patient-centred health risk using an Evidence Based Medicine approach

Who created it and how often is it reviewed and updated?

This health risk assessment is brought to you by Expert-24 Limited. Expert-24 Ltd has full editorial control over content and strives to ensure that the content is:
· Robust - All information used is derived from reputable, referenced sources and subject to rigorous expert review. The content is written by the medical staff of Expert-24 and reviewed by an independent Expert Review Panel. All content is subject to regular review and updated to incorporate the latest evidence. Oxford Health Consulting was commissioned to conduct independent research to determine the model for disease and mortality-specific risks, the contents and its assumptions. The research and statistical modelling behind the risk assessment has been led by Dr. John Fletcher. Dr. Fletcher is deputy editor of the Canadian Medical Association Journal. He holds a Masters degree in Public Health Quantitative Methods and is a member of the Royal College of General Practitioners.
· Independent - The content on the site is provided by Expert-24 Limited, an independent UK company providing knowledge automation and decision support tools to improve health and wellbeing. No member of the Expert Review Panel has any financial stake in Expert-24 Ltd. Content creation and ongoing Quality Assurance is provided by Expert-24 Ltd and its Expert Review Panel.
· Up to date - All clinical material is subject to review by Expert-24 and its Expert Review Panel at least annually.

Why is this health risk assessment different than others?

Most health risk assessments say if a person is at high, medium or low risk of either dying from or developing a given medical condition. Most also indicate what lifestyle factors contribute to this risk. What they do not say is the magnitude of each risk for an individual and how much that person’s risk will decrease if they change their lifestyle. For example, if one is at moderate risk of both bowel cancer and heart disease, most people would be unaware that their risk of heart disease is still five times higher than their risk of bowel cancer.
In order to construct an electronic risk assessment tool for health and disease states, it is necessary to provide supporting research evidence and a method of encapsulating the best estimate of relative risk. For each medical condition, it is necessary to present credible estimates of risk, based on evidence from relevant, peer reviewed medical research. Important features of the risk assessment tool are:
· The tool gives numerical estimates of risk, rather than an imprecise statement such as "increased risk" or "reduced risk".
· The tool has the capability for interaction, allowing users to explore the impact on their personal risk of changing individual risk factors.
· The tool utilises best available medical evidence
The aim of this project is to provide healthy people with a quantitative assessment of their personal risk of developing some important diseases and some of the factors that influence their risk. This is an ambitious task and we would not claim to have produced the definitive approach. Although we believe this is the most informative collection of disease prediction equations available at the present time they do have limitations. The ones we are aware of are outlined below.

What exactly does a given percentage risk mean?

Someone looking at their risk of lung cancer until the age of 50 should read this model as saying, "Assuming survival to age 50 the chance of developing lung cancer during that time would be (some predicted value)". This approach has the appeal that changing risk factors will have the expected impact on cumulative risk and the mathematics remains transparent. We chose the risk of developing a certain condition rather than the risk of dying from it because for many people the fear of living and dealing with a disabling disease is as frightening as dying from it.
This is different than lifetime risk calculations, which generally calculate the risk of dying from a given condition. Lifetime risk must take account of the fact that we all die of something in the end and calculating the relative contribution of common competing causes of death at various ages is difficult. Not only that, but the interpretation by users is complex. For example, a user of an interactive model predicting lifetime risk of lung cancer would see their individual risk of lung cancer fall with increasing cigarette consumption, because they would be dying of heart disease and chronic lung disease before they could get lung cancer.

How accurate are these percentages?

These models are good for illustrating the change in risk due to the presence or absence of single risk factors for prediction times of up to 5 years. They are likely to be reasonably good for 15 or 20 years and for combinations of several risk factors. For longer prediction times and varying more than, say, four risk factors the results should be regarded as illustrative rather than precise. The absolute level of risk for an individual may also be wide of the mark because the majority of overall risk remains unexplained in most research studies. This is why "confidence intervals" have not been included. That said these prediction equations do calculate the best estimate of risk that can be provided on the data given.
Is this useful in the end? We believe it is. We believe that putting some quantification on risk allows users to explore the possible impact on their health of altering what they do. We find this approach more informative than a bland statement of "high risk" that is often value laden or that a certain action will "cut down" a risk without any indication of by how much.

Is risk really reversible?

This is a difficult question to answer, but in many cases the answer seems to be, "yes". This is good news for people with high risks who are older. Intuition might tell you that you are constantly doing damage to your body that accumulates over time, and in many cases that may be true. An example of this is in skin cancer, where the earlier and more often you are badly burned in life, the higher your risk of skin cancer. Staying out of the sun when you are old cannot reverse this risk.
However, there is good evidence that for heart disease, for example, your risks can be significantly reduced no matter what your age. Cholesterol reduction by medications called "statins" reduces the risk of heart attack, angina or sudden death from heart problems by up to 30%, and this is entirely independent of age. Similarly, blood pressure reduction by drugs reduces the risk of stroke and heart disease by 25% - again entirely independent of age. Because in general it is older people who have the highest risks, they actually stand to benefit the most from treatment.
The risk for developing heart disease in tobacco users has been shown to decline to a level comparable with a person who has never smoked within 2-3 years of giving up. Furthermore, the risk of having a stroke is reversed after 5-10 years of stopping. Studies have also shown that life expectancy improves even in people who stop smoking later in life (i.e. at 65 years or older). The risk of lung cancer, however, may not be reversible.
The reduction of risk that can be obtained from changing lifestyle habits such as diet, alcohol consumption and exercise is largely unknown. Therefore, the amount of risk reduction that can be expected from optimising these habits needs to be viewed with caution. Certainly they should not take the place of blood pressure control, cholesterol control, and smoking cessation as goals.

How good is the evidence?

Our aim in searching for evidence was to identify up to ten high quality, relevant research studies for each topic. We used Medline to search using free text, MeSH terms and thesaurus search terms specific to each medical condition. To narrow the documents we used filters using "risk" and study design type; cohorts, case control, longitudinal, follow up. Searches were limited to studies published in English language and human studies. Although a comprehensive systematic review of the literature on each disease was not possible due to the scope of this project, we feel that the evidence used represents a reasonable cross-section of high-quality literature on the subjects in question.
What we have done is to seek out plausible values of relative risk to use in the prediction equations. We have used an approach that searches for high quality research studies and have then applied our judgement tempered by Austin Bradford Hill's criteria for causation when selecting which risks to use. Hill's criteria are: strength, consistency, specificity, temporality, biological gradient, plausibility, coherence, experimental evidence and analogy.
If this sometimes appears somewhat subjective then that is because at times it is a matter of judgement. The judgements have seldom altered the relative risk by more than a small amount. For each risk factor we had to choose a value to use in the model and have been faced at times with a range from which to choose. While a meta analysis may provide the best point estimate, one is not always available and would be spurious to conduct on the sample of studies we have used for each condition. Given the level of uncertainty surrounding an individual's absolute personal risk we are comfortable with a comparatively lesser degree of uncertainty regarding a risk factor's relative risk.

What is the mathematical model that is used?

The actual mathematical and statistical models and risk coefficients that are used to determine risk are proprietary at this time, but have been validated by the authors and reviewers to be appropriate for use in this setting.


Coronary heart disease

Most recently reviewed:

1. Halbert SC et al. Tolerability of red yeast rice (2,400 mg twice daily) versus pravastatin (20 mg twice daily) in patients with previous statin intolerance. Am J Cardiol. 2010 Jan 15;105(2):198-204
2. Lloyd-Jones DM et al. Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction. The American Heart Association’s Strategic Impact Goal Through 2020 and Beyond. Circulation Feb 2, 2010: 586-613

Guidelines reviewed annually:

1. Prevention of cardiovascular disease at population level. National Institute for Health and Clinical Excellence. June 2010
2. Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force, revised 2009.
3. Risk estimation and the prevention of cardiovascular disease. A national clinical guideline, revised 2007. Scottish Intercollegiate Guidelines Network

Articles from previous updates:

1. Brugts JJ, Yetgin T, Hoeks SE, et al. The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials. BMJ 2009;338:b2376.
2. Antithrombotic Trialists' (ATT) Collaboration, Baigent C, Blackwell L, Collins R, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 2009;373(9678):1849-1860.
3. Almgren T, et al. "Stroke and coronary heart disease in treated hypertension - a prospective cohort study over three decades", J Int Med June 2005, 257(6): 496-502
4. Viikari JS, et al. "Risk factors for coronary heart disease in children and young adults", Acta Paediatr Suppl Dec 2004, 93(446): 34-42
5. Knekt P, et al. "Antioxidant vitamins and coronary heart disease risk: a pooled analysis of 9 cohorts", Am J Clin Nutr Dec 2004, 80(6): 1508-20
6. Kaur S, et al. "The impact of environmental tobacco smoke on women's risk of dying from heart disease: a meta-analysis", J Women's Health Oct 2004, 13(8):888-97
7. Ciardullo AV, et al. "Non-HDL cholesterol predicts coronary heart disease in primary prevention: findings from an Italian 40-69 year old cohort in general practice", Monaldi Arch Chest Dis June 2004, 62(2):69-72
8. Pereira MA, et al. "Dietary fiber and risk of coronary heart disease: a pooled analysis of cohort studies", Arch Int Med Feb 2004 164(4):370-6
9. Britton A, Mamot M "Different measures of alcohol consumption and risk of coronary heart diseas and all-cause mortality: 11 year follow-up of the Whitehall II Cohort Study", Addiction Jan 2004 99(1):109-16
10. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. American Heart Association - Professional Association. 2004 Feb (revised 2007 Mar 20).
11. Summary of recommendations for clinical preventive services. American Academy of Family Physicians - Medical Specialty Society. 1996 Nov (revised 2007 Aug).
12. Joint British Societies (2005) JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart 91(Suppl 5), v1-v52.
13. Bobrie, G. et al. Cardiovascular prognosis of "masked hypertension" detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA. 2004 Mar 17;291(11):1342-9.
14. Cooper A, O'Flynn N. Risk assessment and lipid modification for primary and secondary prevention of cardiovascular disease: summary of NICE guidance. BMJ 2008;336:1246-1248.
15. The general public 2008 NICE guideline on cholesterol is available at:
16. Becker DJ, Gordon RY, Halbert SC, et al. Red yeast rice for dyslipidemia in statin-intolerant patients. Annals of Internal Medicine. 2009;150(12):830-39.
17. Rissanen, T.H., "Low intake of fruits, berries and vegetables is associated with excess mortality in men: the Kuopio Ischaemic Heart Disease Risk Factor (KIHD) Study", Journal of Nutrition, 01 Jan 2003, 133(1), 199-204
18. Malyutina, al, "Relation between heavy and binge drinking and all-cause and cardiovascular mortality in Novosibirsk, Russia: a prospective cohort study" Lancet 2002; 360: 1448-54
19. Manson JE et al. Walking compared with vigorous exercise for the prevention of cardiovascular events in women. N Engl J Med 2002 Sep 5;347(10):716-25
20. Yu S. et al, Caerphilly study.What level of physical activity protects against premature cardiovascular death? The Caerphilly study. Heart 2003 May;89(5):502-6
21. Lakka, H.M., "Abdominal obesity is associated with increased risk of acute coronary events in men", European Heart Journal, 01 May 2002; 23(9): 706-13
22. Abbasi, F., "Relationship between obesity, insulin resistance, and coronary heart disease risk.", J Am Coll Cardiol. 04 Sep. 2002; 40(5): 937-43
23. Kannel, W.B., "Risk stratification of obesity as a coronary risk factor.", American Journal of Cardiology, 1 Oct. 2002; 90(7): 697-701
24. Ashton, W.D., "Body mass index and metabolic risk factors for coronary heart disease in women." European Heart Journal, 01 Jan. 2001; 22(1): 46-55
25. Tanasescu, M., "Exercise type and intensity in relation to coronary heart disease in men." JAMA 23 Oct 2002; 288(16): 1994-2000
26. Schnohr, P., "Coronary heart disease risk factors ranked by importance for the individual and community. A 21 year follow-up of 12 000 men and women from The Copenhagen City Heart Study.", European Heart Journal, 01 Apr 2002; 23(8): 620-6
27. Orford, J.L., "A comparison of the Framingham and European Society of Cardiology coronary heart disease risk prediction models in the normative aging study." American Heart Journal, 01 Jul. 2002; 144(1): 95-100
28. Clarke, R., "Underestimation of the importance of blood pressure and cholesterol for coronary heart disease mortality in old age." European Heart Journal, 01 Feb. 2002; 23(4): 286-93


Most recently reviewed:

1. Amarenco P and Labreuche J.”Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention”. Lancet Neurology, Vol. 8 Issue 5, 453-463 May 2009 doi:10.1016/S1474-4422(09)70058-4

Guidelines reviewed annually:

1. Goldstein, L B et al. Primary Prevention of Stroke. AHA/ASA Guideline in Stroke 2006;37:1583-1633

References from previous updates:

1. Antithrombotic Trialists' (ATT) Collaboration, Baigent C, Blackwell L, Collins R, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 2009;373(9678):1849-1860.
2. Connolly SJ, Ezekowitz MD, Yusuf S, et al, for the RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361(12):1139-1151.
3. Almgren T, et al. "Stroke and coronary heart disease in treated hypertension -- a prospective cohort study over three decades." J Intern Med June 2005, 257(6):496-502
4. Bath PM, Gray LJ "Association between hormone replacement therapy and subsequent stroke: a meta-analysis." BMJ 12/02/05 330(7487):342
5. Ni Mhurchu C, et al. "Body mass index and cardiovascular disease in the Asia-Pacific Region: an overview of 33 cohorts involving 310 000 participants." Int J Epidemiol Aug 2004, 33(4):751-8
6. Iso H, et al. "Alcohol consumption and risk of stroke among middle-aged men: the JPHC Study Cohort I." Stroke May 2004 35(5):1124-9
7. Etminan M, et al. "Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies" BMJ. 2005 Jan 8, 330(7482):63
8. Panagiotakos DB, et al. "Risk factors of stroke mortality: a 40-year follow-up of the Corfu cohort from the Seven-Countries Study" Neuroepidemiology, 11/12/2003, 22(6):332-8
9. Bath, P.M. and Gray, L.J. (2005) Association between hormone replacement therapy and subsequent stroke: a meta-analysis. British Medical Journal 330(7487), 342.
10. National Collaborating Centre for Chronic Conditions (2006) Hypertension. Management of hypertension in adults in primary care: pharmacological update (full NICE guideline). Clinical guideline 18 (update). Royal College of Physicians and British Hypertension Society.
11. Stroke prevention. Lipid management. In: Canadian best practice recommendations for stroke care: 2006. Ottawa (ON): Canadian Stroke Network, Heart & Stroke Foundation of Canada; 2006. p. 25-7.
12. Stroke prevention. Blood pressure management. In: Canadian best practice recommendations for stroke care: 2006. Ottawa (ON): Canadian Stroke Network, Heart & Stroke Foundation of Canada; 2006. p. 22-4.
13. Stroke prevention. Life style and risk factor management. In: Canadian best practice recommendations for stroke care: 2006. Ottawa (ON): Canadian Stroke Network, Heart & Stroke Foundation of Canada; 2006. p. 17-21.
14. The 2008 National Institute for Health and Clinical Excellence guideline on cholesterol (public) is available at:
15. EUSI Executive Committee and EUSI Writing Committee, "Ischaemic Stroke Prophylaxis and Treatment", European Stroke Initiative Recommendations 2003
16. Casiglia, E., "Weak effect of hypertension and other classic risk factors in the elderly who have already paid their toll." J Hum Hypertens, 01 Jan 2002; 16(1): 21-31.
17. Lernfelt, B., "Cerebral atherosclerosis as predictor of stroke and mortality in representative elderly population.", Stroke, 01 Jan 2002; 33(1): 224-9.
18. Weverling-Rijnsburger, A.W., "High-Density vs Low-Density Lipoprotein Cholesterol as the Risk Factor for Coronary Artery Disease and Stroke in Old Age.", Arch Intern Med 14 Jul 2003; 163(13): 1549-54.
19. Whisnant, J.P., "Effect of time since onset of risk factors on the occurrence of ischemic stroke." Neurology 12 Mar 2002; 58(5): 787-94.
20. Kernan, W.N., "Insulin resistance and risk for stroke." Neurology 24 Sep 2002; 59(6): 809-15.
21. Vermeer, S.E., "Homocysteine, silent brain infarcts, and white matter lesions: The Rotterdam Scan Study." Ann Neurol 01 Mar 2002; 51(3): 285-9.
22. Wong, T.Y., "Cerebral white matter lesions, retinopathy, and incident clinical stroke." JAMA 3 Jul 2002; 288(1): 67-74.
23. Dey, D.K., "Waist circumference, body mass index, and risk for stroke in older people: a 15 year longitudinal population study of 70- year-olds." J Am Geriatr Soc 01 Sep 2002; 50(9): 1510-8.
24. Wilson, P.W., "Overweight and obesity as determinants of cardiovascular risk: the Framingham experience." Arch Intern Med 9 Sep 2002; 162(16): 1867-72.
25. Hadat, C. et al, "Ethnic differences in cerebrovascular risk factors: A UK case-control study" (unpublished) Accessed at
26. Wassertheil-Smoller, S., "Effect of Estrogen Plus Progestin on Stroke in Postmenopausal Women: The Women's Health Initiative: A Randomized Trial." JAMA, 28 May 2003; 289(20): 2673-84.
27. Lavallée, P., "Association between influenza vaccination and reduced risk of brain infarction."Stroke 01 Feb 2002; 33(2): 513-8.

Breast Cancer

Most recently reviewed:

1. American Cancer Society Guidelines for the early detection of cancer at
2. Duffy, SW et al. Absolute numbers of lives saved and over diagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England. J. Med. Screen 2010; 17:25-30
3. Canadian Expert Panel on Tobacco Smoke and Breast Cancer Risk, April 2009 at
4. Schreer, I. Dense breast tissue as an important risk factor for breast cancer and implications for early detection. Breast Care 2009; 4(2): 89-92.

Guidelines reviewed annually:

NHS Cancer screening programmes at
National Institute for Health and Clinical Excellence at
Risk of breast cancer at
United States Preventive Services Task Force at

Selected articles from previous reviews:

1. Gøtzsche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane Database of Systematic Reviews 2009, Issue 4. Art. No.: CD001877.
2. Tosteson AN, Stout NK, Fryback DG, for the DMIST Investigators. Cost-effectiveness of digital mammography breast cancer screening. Ann Intern Med 2008;148(1):1-10.
3. Sweeney C, Baumgartner KB, Byers T, Giuliano AR, Herrick JS, Murtaugh MA, et al. Reproductive history in relation to breast cancer risk among Hispanic and non-Hispanic white women. Cancer Causes Control. 2008 May ;19(4):391-401.
4. International Menopause Society concensus statement on HRT and risk of cancer at:
5. Benetou, V. et al. Conformity to traditional Mediterranean diet and cancer incidence: Greek EPIC cohort. British J. Ca. (1 July, 2008) 99, 191-195
6. Kushi, L.H. et al. American Cancer Society Guidelines on Nutrition and Physical Activity for Cancer Prevention: Reducing the Risk of Cancer With Healthy Food Choices and Physical Activity CA Cancer J. Clin. 2006; 56 (5):254-281
7. Chlebowski RT, et al. Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study. J Natl Cancer Inst. 2006 Dec 20;98(24):1767-76.
8. Breast Cancer Management - alcohol consumption. Clinical Knowledge Summaries. Minor update May 2007 at:
9. Takkouche B, et al. "Personal use of hair dyes and risk of cancer: a meta-analysis." JAMA May 25, 2005, 293(20):2516-252.
10. Duijts SF, et al. "The association between stressful life events and breast cancer risk: a meta-analysis." Int J Cancer Dec. 20, 2003, 107(6):1023-9
11. Boyd NF, et al. "Dietary fat and breast cancer risk revisited: a meta-analysis of the published literature." Br J Cancer Nov 2003, 89(9):1672-85
12. McTiernan A, et al. "Recreational physical activity and the risk of breast cancer in postmenopausal women: the Women's Health Initiative Cohort Study." JAMA 10/09/
13. Calle EE, et al. "Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults." N Engl J Med Apr 24, 2003, 348(17):1625-38
14. Rossouw JE et al. "Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial." JAMA 2002 Jul 17 288(3):321-33.
15. Ellison RC et al. "Exploring the relation of alcohol consumption to risk of breast cancer" Am J Epidemiol. Oct 15, 2001; 154(8):740-7.
16. Key, T.J. et al, "Epidemiology of breast cancer." Lancet Oncology 01 Mar 2001; 2(3): 133-40
17. Hamajima, N. et al, "Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease." British Journal of Cancer, 18 Nov 2002; 87(11): 1234-45
18. Bianchini, F., "Overweight, obesity, and cancer risk." Lancet Oncology 01Sep 2002; 3(9): 565-74
19. Lahmann, P.H., "A prospective study of adiposity and postmenopausal breast cancer risk: The Malmö diet and cancer study." International Journal of Cancer 10 Jan 2003; 103(2): 246-52
20. Boyd, N.F., "Heritability of mammographic density, a risk factor for breast cancer." New England Journal of Medicine 19 Sep 2002; 347(12): 886-94
21. Lillberg, K., "Stressful life events and risk of breast cancer in 10,808 women: a cohort study." American Journal of Epidemiology 1 Mar 2003; 157(5): 415-23
22. Kropp, S., "Active and passive smoking and risk of breast cancer by age 50 years among German women." American Journal of Epidemiology 1 Oct 2002; 156(7): 616-26
23. Egan, K.M., "Active and passive smoking in breast cancer: prospective results from the Nurses' Health Study." Epidemiology 01 Mar 2002; 13(2): 138-45
24. Band, P.R., "Carcinogenic and endocrine disrupting effects of cigarette smoke and risk of breast cancer." Lancet 5 Oct 2002; 360(9339): 1044-9
25. Layde, P.M., "The independent associations of parity, age at first full term pregnancy, and duration of breastfeeding with the risk of breast cancer. Cancer and Steroid Hormone Study Group." Journal of Clinical Epidemiology 01 Jan 1989; 42(10): 963-73
26. Lipworth, L., "History of breast-feeding in relation to breast cancer risk: a review of the epidemiologic literature." Journal of the National Cancer Institute, 16 Feb 2000; 92(4): 302-12
27. Little, M.P., "Comparison of breast cancer incidence in the Massachusetts tuberculosis fluoroscopy cohort and in the Japanese atomic bomb survivors." Radiation Research, 01 Feb 1999; 151(2): 218-24
28. Doody, M.M., "Mortality among United States radiologic technologists, 1926-90." Cancer Causes Control, 01 Jan 1998; 9(1): 67-75
29. Evans, J.S., "The influence of diagnostic radiography on the incidence of breast cancer and leukemia." New England Journal of Medicine 25 Sep 1986; 315(13): 810-5
30. Eunyoung, C., et al, "Premenopausal Fat Intake and Risk of Breast Cancer" Journal of the National Cancer Institute, Vol. 95, No. 14, 1079-1085, July 16, 2003
31. Clavel-Chapelon, F., "Differential effects of reproductive factors on the risk of pre- and postmenopausal breast cancer. Results from a large cohort of French women." British Journal of Cancer 4 Mar 2002; 86(5): 723-7
32. Holmes MD, et al. "Physical activity and survival after breast cancer diagnosis". JAMA 5 May 2005; 293(20):2479-86
33. Key TJ, et al. "Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women" J Natl Cancer Inst. 20 Aug. 2003; 95(16):1218-26
34. Duijts SF, et al. "The association between stressful life events and breast cancer risk: a meta-analysis." Int J Cancer 20 December 2003; 107(6):1023-9
35. Collaborative group on hormonal factors in breast cancer, "Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies", Lancet, 1996 347:1713-1727
36. Colditz, et al, "Family History, Age and Risk of Breast Cancer; Prospective data from the Nurses Health Study", JAMA 1993 270: 338-343
37. Schairer, et al, "Menopausal Estrogen and Progestin-Estrogen Replacement therapy and Breast Cancer Risk", JAMA 2000 283: 485-491

Lung Cancer

Most recently reviewed:

Guidelines reviewed annually:
1. NHS Information for patients on the nature of cancer.
2. NHS Cancer screening programmes.

Selected articles from previous reviews:

1. The International Early Lung Cancer Action Program Investigators, Henschke CI, Yankelevitz DF, et al. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 2006;355:1763-1771.
2. Wilson DO, Weissfeld JL, Fuhrman CR, et al. The Pittsburgh Lung Screening Study (PLuSS): outcomes within 3 years of a first computed tomography scan. Am J Respir Crit Care Med 2008;178(9):956-961.
3. Yun YH, et al. "Cigarette smoking and cancer incidence risk in adult men: National Health Insurance Corporation Study" Cancer Detect Prev. 2005 29(1):15-24.
4. Zhang B, et al. "Smoking cessation and lung cancer mortality in a cohort of middle-aged Canadian women", Ann Epidemiol April 2005, 15(4):302-9
5. Lee PN, Sanders E "Does increased cigarette consumption nullify any reduction in lung cancer risk associated with low-tar filter cigarettes?", Inhal Toxicol 16/03/05, 16(13):817-33
6. Clifford GM, et al. "Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy." J Natl Cancer Inst March 16, 2005, 97(6):425-32
7. Marugame T, et al. "Lung cancer death rates by smoking status: comparison of the Three-Prefecture Cohort study in Japan to the Cancer Prevention Study II in the USA" Cancer Sci. Feb 2005, 96(2):120-6
8. Vineis P, et al. "Environmental tobacco smoke and risk of respiratory cancer and chronic obstructive pulmonary disease in former smokers and never smokers in the EPIC prospective study." BMJ May 2, 2005, 330(7486):277
9. Eichholzer M, et al. "Body mass index and the risk of male cancer mortality of various sites: 17-year follow-up of the Basel cohort study." Swiss Med Wkly Jan 8, 2005, 135(1-2):27-33
10. Mannisto S, et al "Dietary carotenoids and risk of lung cancer in a pooled analysis of seven cohort studies" Cancer Epidemiol Biomarkers Prev Jan 2004, 13(1):40-8
11. Riboli E, Norat T "Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk." Am J Clin Nutr Sep 2003, 78(3 Suppl):559S-569S.
12. Bilello, K.S., "Epidemiology, etiology, and prevention of lung cancer", Clinics in Chest Medicine, 01 March 2002; 23(1): 1-25.
13. Reid, M.E. et al, "Selenium supplementation and lung cancer incidence: an update of the nutritional prevention of cancer trial", Cancer Epidemiology, Biomarkers and Prevention, 2002 Nov;11(11):1285-91.
14. Korte, J.E., "Dose-specific meta-analysis and sensitivity analysis of the relation between alcohol consumption and lung cancer risk", American Journal of Epidemiology, 15 March 2002; 155(6): 496-506.
15. Ezzati, al, and the Comparative Risk Assessment Collaborating Group, "Selected major risk factors and global and regional burden of disease", The Lancet, 2 Nov 2002, 360 (9343): 1347-60
16. Alberg, A. and Samet, J., "Epidemiology of Lung Cancer", Chest, 01 Jan 2003; 123 (1 suppl): 21S-49S
17. Doll and Peto, "Mortality and relation to smoking: 20 yrs observations on male British Doctors", BMJ 1976 2: 1525-1536
18. Doll et al, "Mortality in relation to smoking:22 years observations on female British doctors", BMJ 5/4/80 p 967-971
19. Kreuzer et al, "Lung cancer in non smoking men - results of a case control study in Germany", British Journal of Cancer 2001 84:134-140
20. Wald et al, "Does breathing other peoples smoke cause lung cancer?", BMJ 8 November 1986 293:121-1222
21. Gustavsson et al "Occupational exposure and lung cancer risk: A population based case referent study in Sweden", American Journal of Epidemiology 152: 32-40
22. Bromen et al, "Aggregation of lung cancer in families: Results from a population based case control study in Germany", American Journal of Epidemiology 152:497-505
23. Floderus et al, "Smoking and mortality: A 21 yr Follow up based on the Swedish Twin Registry", International Journal of Epidemiology 1988, 17:332-340:
24. Yuan et al, "Morbidity and mortality in relation to cigarette smoking in Shanghai, China: A prospective male cohort study", JAMA 1996:275 1646-1650
25. Benhamou et al, "Lung cancer risk associated with cigar and pipe smoking", Int J Cancer 1986 37:825-829
26. Feskanich et al, "Prospective study of fruit and vegetable consumption and risk of lung cancer among men and women", J Natl Cancer Inst 2000;92 1812-23
27. Katsoyanni et al, "A case control study of air pollution and tobacco smoking in lung cancer among women in Athens Preventive medicine", 1991 20 271-8
28. Van Loon et al, "Occupational exposure to carcinogens and risk of lung cancer:Results from the Netherlands cohort study", Occupational and Environmental medicine 1997 54:817-24
29. Shekelle et al, "Dietary vitamin A and the risk of lung cancer in the Western Electric Study", Lancet 28/11/1981 p 1185-1189
30. Alavanja M.C.R. et al, "Lung cancer risk and red meat consumption among Iowa women", Lung Cancer 2001:34;37-46
31. Cook N.R., et al, "Effects of beta-carotene supplementation on cancer incidence by baseline characteristics in the Physician's Health Study (United States)", Cancer Causes and Control 2000:11;617-626.

Prostate Cancer

Most recently reviewed:

1. Wolf A, Wender R, Etzioni R, et al; American Cancer Society Prostate Cancer Advisory Group. American Cancer Society Guideline for the Early Detection of Prostate Cancer: Update 2010. CA Cancer J Clin 2010; 60: 70-98
2. Andriole, GL et al; Mortality results from a randomized prostate cancer screening trial. N Eng J Med 2009;360:1310-1319
3. Schroder, FH et al; Screening and prostate-cancer mortality in a randomized European study. N Eng J Med 2009;360:1320-1328

Selected articles from previous reviews:

1. U.S. Preventive Services Task Force. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008 Aug 5;149(3):185-91.
2. National Institute for Health and Clinical Excellence 2008 Guideline on Prostate Cancer:
3. Ilic D, O'Connor D, Green S, Wilt T. Screening for prostate cancer. Cochrane Database of Systematic Reviews 2006, Issue 3. Art. No.: CD004720. DOI: 10.1002/14651858.CD004720.pub2.
4. Prevention of Prostate Cancer. National Cancer Institute, April 2006.
5. Dagnelie PC, et al. "Diet, anthropometric measures and prostate cancer risk: a review of prospective cohort and intervention studies." BJU Int May 2004, 93(8):1139-50
6. Johns LE, Houlston RS "A systematic review and meta-analysis of familial prostate cancer risk." BJU Int June 2003, 91(9):789-94
7. Dennis LK, et al. "Problems with the assessment of dietary fat in prostate cancer studies." Am J Epidemiol Sep 1, 2004, 160(5):436-44
8. Bonovas S, et al. "Diabetes mellitus and risk of prostate cancer: a meta-analysis." Diabetologia June 2004, 47(6):1071-8.
9. Dagnelie PC, et al. "Diet, anthropometric measures and prostate cancer risk: a review of prospective cohort and intervention studies" BJU Int May 2004, 93(8):1139-50
10. Brouwer IA, et al. "Dietary alpha-linolenic acid is associated with reduced risk of fatal coronary heart disease, but increased prostate cancer risk: a meta-analysis." J Nutr Apr 2004, 134(4):919-22
11. Etminan M, et al. "The role of tomato products and lycopene in the prevention of prostate cancer: a meta-analysis of observational studies" Cancer Epidemiol Biomarkers Prev Mar 2004, 13(3):340-5
12. Giovannucci EL et al. "A prospective study of physical activity and incident and fatal prostate cancer." Arch Intern Med. 2005 May 9, 165(9):1005-10.
13. Lippmann et al. Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers. JAMA 2009; 301: 39-51
14. Gaziano et al. Vitamins E and C in the Prevention of Prostate and Total Cancer in Men: The Physicians' Health Study II RCT. JAMA 2009; 301:52-62
15. Damber and Aus. Prostate Cancer. Lancet 2008; 371: 1710-21
16. Terry, P. et al, "Fatty fish consumption and risk of prostate cancer", The Lancet, June 2001 Volume 357 Issue 9270 Page 1764
17. Boyle, P., "The epidemiology of prostate cancer", Urol Clin North America, 01 May 2003; 30(2): 209-17
18. Johns, L.E., "A systematic review and meta-analysis of familial prostate cancer risk.", BJU Int, 01-JUN-2003; 91(9): 789-94.
19. Zeegers, M.P., "Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma", Cancer, 15 Apr 2003; 97(8): 1894-903.
20. Dennis, L.K., "Meta-analysis of measures of sexual activity and prostate cancer", Epidemiology, 01 Jan 2002; 13(1): 72-9.
21. Dennis, L.K., "Epidemiologic association between prostatitis and prostate cancer", Urology, 01 Jul 2002; 60(1): 78-83.
22. Smith, D.S., "Racial differences in a prostate cancer screening study", Journal of Urology, 01 Oct 1996; 156(4): 1366-9.
23. Lynge, E., "Prostate cancer is not increased in men with vasectomy in Denmark", Journal of Urology, 01 Aug 2002; 168(2): 488-90.

Bowel Cancer

Most recently reviewed:

1. Limsui D et al. Cigarette smoking and colorectal cancer risk by molecularly defined subtypes. JNCI 2010; 102(14): 1012-1022
2. Gonzalez CA and Riboli E. Diet and cancer prevention: Contributions from the European Prospective Investigation into Cancer and Nutrition (EPIC) study. European Journal of Cancer 2010; 46: 2555-2562.
3. Soderlund S et al. Inflammatory bowel disease confers a lower risk of colorectal cancer to females than to males. Gastroenterology Vol 138, Issue 5, 1697-1703, May 2010.
4. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials Peter M Rothwell, Michelle Wilson, Carl-Eric Elwin, Bo Norrving, Ale Algra, Charles P Warlow, Tom W Meade Lancet 2010; 376: 1741–50
5. Van Duijnhoven, FJB et al. Fruit, vegetables, and colorectal cancer risk: the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr 2009; 89: 1441-1452.
6. Wolin KY et al. Physical Activity and colon cancer prevention: a meta-analysis. British J Cancer (10 Feb. 2009) 100, 611-616.
7. Freedman, AN et al. Colorectal Cancer Risk Prediction Tool for White Men and Women Without Known Susceptibility. J Clin Onc 2009 (vol.27 no.5): 686-693
8. Edoardo Botteri, M.Sc. et al. Smoking and Colorectal Cancer: a meta-analysis. JAMA 2008; 300(23): 2765-2778.
9. Levin, B et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008. A joint guideline from the American Cancer Society, the US Multi-society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 2008; 58: 130-160.
10. Larsson DC, Wolk A. Obesity and colon and rectal cancer risk: meta-analysis of prospective studies. Am. J. Clin. Nutr. 2007 Sep; 86 (3): 556-65.
11. Park Y et al. Fruit and Vegetable Intakes and Risk of Colorectal Cancer in the NIH-AARP Diet and Health Study. Am J Epidemiology 2007; 166(2): 170-180
12. Itzkowitz SH and Yio X. Inflammation and Cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol. Gastro Liver Physio 287:G7-G17, 2004

Guidelines reviewed annually:

1. NHS Cancer screening programmes at:
2. US National Cancer Institute at: and
Selected articles from previous reviews:
1. Benetou, V. et al. Conformity to traditional Mediterranean diet and cancer incidence: Greek EPIC cohort. British J. Ca. (1 July, 2008) 99, 191-195
2. Segnan N, Senore C, Andreoni B, et al, for the SCORE3 Working Group-Italy. Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening. Gastroenterology 2007;132(7):2304-2312.
3. Kushi, L.H. et al. American Cancer Society Guidelines on Nutrition and Physical Activity for Cancer Prevention: Reducing the Risk of Cancer With Healthy Food Choices and Physical Activity CA Cancer J. Clin. 2006; 56 (5):254-281
4. Sanjoaquin MA et al. "Folate intake and colorectal cancer risk: a meta-analytical approach", Int J Cancer Feb 2005, 113(5): 825-8.
5. Cho E et al. :Dairy foods, calcium and colorectal cancer: a pooled analysis of 10 cohort studies", J Natl Cancer Inst. July 2004, 96(13): 1015-22.
6. Colangelo LA et al. "Cigarette smoking and colorectal carcinoma mortality in a cohort with long-term follow-up", Cancer Jan 2004 100(2): 288-93
7. Key TJ et al. "Diet, nutrition and the prevention of cancer", Public Health Nutr. Feb 2004 7(1A): 187-200
8. Weingarten MA et al. "Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps. Cochrane Database 2004 (1)CD 003548.
9. Flanders WD et al. "Meat consumption and risk of colorectal cancer", JAMA Jan 12, 2005 293(2):172-82.
10. Giovannucci, E., "Modifiable risk factors for colon cancer", Gastroenterology Clinics of North America, 01 Dec 2002; 31(4): 925-43.
11. Slattery, M.L., "Physical activity and colon cancer: confounding or interaction?" Medicine and Science in Sports and Exercise. 01 June 2002; 34(6): 913-9.
12. Juarranz, M., "Physical exercise, use of Plantago ovata and aspirin, and reduced risk of colon cancer", European Journal of Cancer Prevention, 01 Oct 2002; 11(5): 465-72.
13. Bianchini, F., "Overweight, obesity, and cancer risk", Lancet Oncology, 01 Sep 2002; 3(9): 565-74.
14. Wu, K., "Calcium intake and risk of colon cancer in women and men", Journal of the National Cancer Institute, 20 March 2002; 94(6): 437-46.
15. Almendingen, K., "Lifestyle-related factors and colorectal polyps: preliminary results from a Norwegian follow-up and intervention study", European Journal of Cancer Prevention, 01 April 2002; 11(2): 153-8.
16. Jarvinen et al, "Dietary fat, cholesterol and colorectal cancer in a prospective study", Br J Cancer 2001:85:357-61
17. Fuchs et al, "Dietary fibre and the risk of colorectal cancer and adenoma in women", NEJM 1999:340:169-76
18. Fernandez et al, "Oral contraceptives and colorectal cancer risk: a meta analysis", Br. J Cancer 2001 84:722-7
19. Lund Nilsen et al, "Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose, and BMI: exploring the hyperinsulinaemia hypothesis", Br. J of Cancer 2001 84:417-22
20. Michels et al, "Prospective study of fruit and vegetable consumption and incidence of colon and rectal cancers", J Natl Cancer Inst 2000; 92:1740-52
21. Terry et al, "Fruit, vegetables, dietary fibre and risk of colorectal cancer", J of Natl Cancer Inst. 2001; 93 525-33
22. Terry et al, "Prospective study of major dietary patterns and colorectal cancer risk in women", American Journal of Epidemiology 2001 154:1143-49
23. Terry et al, "Coffee consumption and risk of colorectal cancer in a population based prospective cohort of Swedish women", Gut 2001 49:87-90
24. Lindgren et al Gut, "Adenoma prevalence and cancer risk in familial non polyposis colorectal cancer", 2002 50:228-34
25. Singh et al, "Dietary risk factors for colon cancer in a low risk population", American Journal of Epidemiology 1998 148:761-4
26. Giovannucci E et al. Physical Activity, Obesity and Risk for Colon Cancer and Adeoma in Men. Ann Inter Med 1995;122:327-334
27. Fuchs et al, "A prospective study of family history and the risk of colorectal cancer", NEJM 1994 331:1669-74
28. St.John et al, "Cancer risk in relatives of patients with common colorectal cancer", Annals of Internal Medicine 1993; 118:785-790
29. Howe et al, "Dietary intake of fibre and decreased risk of cancers of the colon and rectum: evidence from the combined analysis of 13 case control studies", J Natl Cancer Inst 1992; 84:1887-1894
30. Thun et al, "Risk factors for fatal colon cancer in a large prospective study", J Natl Cancer Inst 1992; 84:1491-1499
31. Shibata et al, "Intake of vegetables, fruits, beta carotene, vitamin C and vitamin supplements and cancer incidence among the elderly: a prospective study", Br. J of Cancer 1992; 66:673-679


Most recently reviewed:

1. Carter et al, BMJ 2010; 341 c4229, Fruit & vegetable intake and incidence of type 2 diabetes: systematic review and meta analysis
2. Solomon, D et al. Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis. Ann Rheum Dis 2010;69:2114-2117
3. Weycker D et al. Excess risk of diabetes in persons with hypertension. J Diabetes Complications 1 Sep 2009;23(5): 330-6

Guidelines reviewed annually:

1. National Collaborating Centre for Chronic Conditions. Type 2 diabetes: national clinical guideline for management in primary and secondary care (update). London: Royal College of Physicians, 2008.
2., accessed November 21, 2010

Selected articles from previous reviews:

1. Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore, BMJ 2009;338:b880
2. Elvira Luján Massó-González et al. Trends in the Prevalence and Incidence of Diabetes in the UK - 1996 to 2005 J Epidemiol Community Health doi:10.1136/jech.2008.080382
3. Guangwei Li et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet 2008; 371:1783-89
4. Nield L, Summerbell CD, Hooper L, Whittaker V, Moore H. Dietary advice for the prevention of type 2 diabetes mellitus in adults. Cochrane Database of Systematic Reviews 2008, Issue 3. Art. No.: CD005102. DOI: 10.1002/14651858.CD005102.pub2.
5. Choi HK, et al. "Dairy consumption and risk of type 2 diabetes mellitus in men: a prospective study", Arch Int Med May 9, 2005, 165(9): 997-1000
6. Weinstein AR, et al. "Relationship of physical activity vs body mass index with type 2 diabetes in women", JAMA Sep 8, 2004, 292(10): 1188-94
7. Whincip PH, et al. "British South Asians aged 13-16 years have higher fasting glucose and insulin levels than Europeans", Diab Med Sep 2005 22(9):1275-7
8. Lauenborg J "The prevalence of Metabolic Syndrome in a Danish population of women with previous gestational diabetes is three fold higher than in the general population" J Clin Endocrin Metab July 2005 90(7): 4004-10
9. Damm P "Predictive factors for the development of diabetes in women with previous gestational diabetes mellitus", Am J Obst Gyn Sep 1992 167(3): 607-16
10. Bhargava, A., "A longitudinal analysis of the risk factors for diabetes and coronary heart disease in the Framingham Offspring Study", Popul Health Metr. 2003; 1 (1): 3
11. Schaefer-Graf, U.M., "Clinical predictors for a high risk for the development of diabetes mellitus in the early puerperium in women with recent gestational diabetes mellitus." Am J Obstet Gynecol. 01 Apr 002; 186(4): 751-6.
12. Verma, A., "Insulin resistance syndrome in women with prior history of gestational diabetes mellitus." J Clin Endocrinol Metab 01 Jul 2002; 87(7): 3227-35.
13. Albareda, M., "Diabetes and abnormal glucose tolerance in women with previous gestational diabetes." Diabetes Care 01 Apr 2003; 26(4): 1199-205.
14. Legro, R.S., "Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women." J Clin Endocrinol Metab 01 Jan 1999; 84(1): 165-9.
15. Yildiz, B.O., "Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome." J Clin Endocrinol Metab 01 May 2003; 88(5): 2031-6.
16. Ehrmann, D.A., "Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome." Diabetes Care 01 Jan 1999; 22(1): 141-6.
17. Legro, R.S., "Diabetes prevalence and risk factors in polycystic ovary syndrome." Obstet Gynecol Clin North Am 01 Mar 2001; 28(1): 99-109.

All Cause Mortality

Most recently reviewed:

Mitrou PN, Kipnis V, Thiébaut ACM, et al. Mediterranean Dietary Pattern and Prediction of All-Cause Mortality in a US Population: Results From the NIH-AARP Diet and Health Study. Archives of Internal Medicine. 2007;167(22):2461-8.
Sofi F, Cesari F, Abbate R, et al. Adherence to Mediterranean diet and health status: meta-analysis. British Medical Journal. 2008;337:a1344-50.
White, IR, Altmann, DR, Nanchahal, K. Alcohol consumption and mortality: modeling risks for men and women at different ages. BMJ 2002 Vol 325: 191
Gaziano, JM et al. Light to Moderate Alcohol Consumption and Mortality in the Physician’s Health Study Enrollment Cohort. J Am Coll. Card. 2000: Vol 35. No 1.
Thun, MJ et al. Alcohol consumption and Mortality among Middle-Aged and Elderly US Adults. NEJM 1997; 337: 1705-1714

Selected articles from previous reviews:

1. Khaw, KT, et al. Combined Impact of Health Behaviours and Mortality in Men and Women: The EPIC Norfolk Prosepctive Population Study. PLoS
2. Med 5(1): e12. doi:10.1371/journal.pmed.0050012 (January 8, 2008)
3. Benetou, V. et al. Conformity to traditional Mediterranean diet and cancer incidence: Greek EPIC cohort. British J. Ca. (1 July, 2008) 99, 191-195
4. Kushi, L.H. et al. American Cancer Society Guidelines on Nutrition and Physical Activity for Cancer Prevention: Reducing the Risk of Cancer With Healthy Food Choices and Physical Activity CA Cancer J. Clin. 2006; 56 (5):254-281
5. Chlebowski RT, et al. Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study. J Natl Cancer Inst. 2006 Dec 20;98(24):1767-76.
6. Michels, K.B., "A prospective study of variety of healthy foods and mortality in women." Int J Epidemiol 01 Aug 2002; 31(4): 847-54.
7. Katzmarzyk, P.T., "Adiposity, adipose tissue distribution and mortality rates in the Canada Fitness Survey follow-up study." Int J Obes Relat Metab Disord 01 Aug 2002; 26(8): 1054-9.
8. Andersen, L.B., "All-cause mortality associated with physical activity during leisure time, work, sports, and cycling to work." Arch Intern Med 12 Jun 2000; 160(11): 1621-8
9. Prescott, E., "Importance of light smoking and inhalation habits on risk of myocardial infarction and all cause mortality. A 22 year follow up of 12 149 men and women in The Copenhagen City Heart Study." J Epidemiol Community Health 01 Sep 2002; 56(9): 702-6
10. Fraser, G.E., "Association among health habits, risk factors, and all-cause mortality in a black California population.", Epidemiology, Mar 1997; 8 (2): 168-74.
11. Tilling, K., "Estimating the effect of cardiovascular risk factors on all-cause mortality and incidence of coronary heart disease using G-estimation: the atherosclerosis risk in communities study." American Journal of Epidemiology 15 Apr 2002; 155(8): 710-8
12. Yuan et al, "Follow up study of moderate alcohol intake and mortality among middle-aged men in Shanghai, China", BMJ 1997 314:18-23
13. Fuchs et al, "Alcohol consumption and mortality amongst women", NEJM 1995 332:1245-1250
14. Wannamethee et al, "Lifelong teetotallers, Ex drinkers and Drinkers: Mortality and the incidence of major coronary heart disease events in middle aged British men", International Journal of Epidemiology 1997 26:523-531
15. Thun et al, "Alcohol consumption and mortality among middle aged and elderly US adults", NEJM 1997 337:1705-1713
16. Hart et al, "Alcohol consumption and mortality from all causes, coronary heart disease and stroke: results from a prospective cohort study of Scottish men with 21 yrs follow up", BMJ 1999:318:1725-9
17. "Diabetes mellitus, coronary heart disease incidence and death from all causes in African American and European American women". The NHANES I epidemiologic follow up study
18. Lotufo et al , "Diabetes and all cause and coronary heart disease mortality among US male physicians", Arch Intern Med 2001; 161:242-7
19. Lotufo et al, "Diabetes and all cause and coronary heart disease mortality among US male physicians", Arch Intern Med 2001; 161:242-7
20. Stamler et al, "Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long term coronary, cardiovascular and all cause mortality and to longevity", JAMA 2000;284:311-8
21. Doll and Peto, "Mortality and relation to smoking: 20 yrs observations on male British Doctors", BMJ 1976: 2:1525-1536
22. Doll et al, "Mortality in relation to smoking:22 years observations on female British doctors", BMJ 5/4/80 p 967-971
23. Jacobs et al, "Cigarette smoking and mortality risk. Twenty five year follow up of the seven countries study", Arch Intern Med 1999; 159:733-40
24. I Min Lee et al, "Body weight and mortality, a 27 yr follow up of middle-aged men", JAMA 1993;270:2823-8
25. Blair et al, "Body weight change, all cause mortality in the multiple risk factor intervention trial", Ann Intern Med 1993;119:749-57
26. Seidell et al, "Overweight, underweight and mortality. A prospective study of 48287 men and women", Arch Intern Med. 1996;156:958-63
27. Manson et al, "Body weight and mortality among women", NEJM 1995; 333:677-85
28. Colditz et al, "Oral contraceptive use and mortality during 12 years of follow up: The Nurses Health Study", Ann Intern Med. 1994;120:821-6
29. Morris et al, "Loss of employment and mortality", BMJ 1994; 308:1135-9
30. Martikainen et al, "Income differences in mortality: a register based follow up study of three million men and women", Int Journal of Epidemiology 2001; 30:1397-1405)
31. Matthews et al, "Chronic work stress and marital dissolution increase risk of post-trial mortality in men from the MRFIT", Arch Intern Med. 2002;162:309-15
32. Ben Schlomo et al, "Magnitude and causes of mortality differences between married and unmarried men", J Epidemiol Community Health 1993;47:200-5
33. Kawachi et al, "A prospective study of social networks in relation to total mortality and cardiovascular disease in men in the USA", J Epidemiology and Community Health 1996;50:245-251
34. "The diet and all cause death rate in the Seven Countries Study", The Lancet July 11, 1981;58-61
35. Huovinen et al, "Mortality of adults with asthma; a prospective cohort study", Thorax 1997; 52:49-54
36. Johansen et al, "Important risk factors for death in adults: a 10 yr follow up of the Nutrition Canada survey cohort", CMAJ 136:823-8
37. Knuiman et al, "Lung function, respiratory symptoms, and mortality. Results from the Busselton Health Study", Ann Epidemiol 1999;9:297-306
38. Dockery et al, "An association between air pollution and mortality in six US cities", NEJM 1993;329:1753-9
39. Wannamethee S.G. et al, "Lifestyle and 15 year survival free of heart attack, stroke and diabetes in middle aged British Men", Archives of Internal Medicine 1998:158; 2433-2440
40. Strandberg T.E. et al, "Blood pressure and mortality during an up to 32 year follow up", Journal of Hypertension 2001:19;35-39.
41. Haapanen N. et al, "Characteristics of leisure time physical activity associated with decreased risk of premature all cause and cardiovascular disease mortality in middle aged men", American Journal of Epidemiology, 1996:143;870-80.
42. Keil U., et al, "Classical risk factors and their impact on incident non-fatal and fatal myocardial infarction and all cause mortality in southern Germany (MONICA Augsburg cohort)", The European Heart Journal 1998:19;1197-1207.